Intensive chemotherapy improved outcomes for peripheral T-cell lymphomas (PTCL) patients. This approach led to a 67% complete remission rate and a 52% overall survival at three years.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: